ConductScience.org, home

Paper32451908

Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.

Liu XI and 9 others. Clin Pharmacokinet, 2020. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling. Papers, record 32451908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32451908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2026-11-02
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu XIXiaomei I
2Momper JDJeremiah D
3Rakhmanina NYNatella Y
4Green DJDionna J
5Burckart GJGilbert J
6Cressey TRTim R
7Mirochnick MMark
8Best BMBrookie M
9van den Anker JNJohn N
10Dallmann AAndré

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
HIV Integrase InhibitorsMajor topic
Heterocyclic Compounds, 3-RingMajor topic
OxazinesMajor topic
PiperazinesMajor topic
PyridonesMajor topic
Raltegravir PotassiumMajor topic
Female
Fetus
Humans
Maternal Exposure
Placenta
Pregnancy
Dolutegravir

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 HD087969NICHD NIH HHSUnited StatesT32HD087969PubMed and NIHNIH RePORTER
UM1 AI068616NIAID NIH HHSUnited StatesUM1AI068616PubMed and NIHNIH RePORTER
UM1AI068632NIHNIH RePORTER
UM1AI106716NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00042289Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After PregnancyResults

Source ClinicalTrials.gov

Download CSV of trials

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116639716Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.J Pharm Sci2006https://conductscience.org/library/papers/16639716PubMed
230265616Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States.Public Health Rep2018https://conductscience.org/library/papers/30265616PubMed
36796071The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver.Biochem J1981https://conductscience.org/library/papers/6796071PubMed
43286084The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.Clin Pharmacokinet1988https://conductscience.org/library/papers/3286084PubMed
528401479Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.Clin Pharmacokinet2017https://conductscience.org/library/papers/28401479PubMed
618581209Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.Pharm Res2008https://conductscience.org/library/papers/18581209PubMed
720457591Effect of low-, moderate-, and high-fat meals on raltegravir pharmacokinetics.J Clin Pharmacol2011https://conductscience.org/library/papers/20457591PubMed
819884365Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/19884365PubMed
911170034Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs.J Pharm Sci2001https://conductscience.org/library/papers/11170034PubMed
1028319246Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013.JAMA Pediatr2017https://conductscience.org/library/papers/28319246PubMed
1126538508Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model.J Antimicrob Chemother2016https://conductscience.org/library/papers/26538508PubMed
1215858854Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.J Pharm Sci2005https://conductscience.org/library/papers/15858854PubMed
1322945404A framework for elimination of perinatal transmission of HIV in the United States.Pediatrics2012https://conductscience.org/library/papers/22945404PubMed
1426898568Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.Eur J Clin Pharmacol2016https://conductscience.org/library/papers/26898568PubMed
1517133211Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.J Acquir Immune Defic Syndr2006https://conductscience.org/library/papers/17133211PubMed
164520389Drug-protein binding in the newborn infant.Ann N Y Acad Sci1973https://conductscience.org/library/papers/4520389PubMed
1732109493Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review.Eur J Pharm Sci2020https://conductscience.org/library/papers/32109493PubMed
1826552713Evaluation of the impact of multivalent metal ions on the permeation behavior of Dolutegravir sodium.Drug Dev Ind Pharm2016https://conductscience.org/library/papers/26552713PubMed
1923515248Predicting intestinal absorption of raltegravir using a population-based ADME simulation.J Antimicrob Chemother2013https://conductscience.org/library/papers/23515248PubMed
2024096683Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment.Eur J Clin Pharmacol2014https://conductscience.org/library/papers/24096683PubMed

See all 74 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42778687Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state.J Pharmacokinet Pharmacodyn2026https://conductscience.org/library/papers/42778687PubMed
41983686Physiologically-based pharmacokinetic modelling of uridine 5'-diphosphoglucorosultransferase (UGT) substrate drugs in pregnant women.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41983686PubMed
41221050Strategy advancements in placental pharmacokinetics: from in vitro experiments to in silico prediction.Front Pharmacol2025https://conductscience.org/library/papers/41221050PubMed
39066420Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics.Vaccines (Basel)2024https://conductscience.org/library/papers/39066420PubMed
38973651Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms.J Clin Pharmacol2024https://conductscience.org/library/papers/38973651PubMed
38517686Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential.Expert Rev Anti Infect Ther2024https://conductscience.org/library/papers/38517686PubMed
38340019Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy.Br J Clin Pharmacol2025https://conductscience.org/library/papers/38340019PubMed
36365185Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine.Pharmaceutics2022https://conductscience.org/library/papers/36365185PubMed
34805038Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models.Front Pediatr2021https://conductscience.org/library/papers/34805038PubMed
34733804Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?Front Pediatr2021https://conductscience.org/library/papers/34733804PubMed
34722417Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development.Front Pediatr2021https://conductscience.org/library/papers/34722417PubMed
34631628Mechanistic Coupling of a Novel in silico Cotyledon Perfusion Model and a Physiologically Based Pharmacokinetic Model to Predict Fetal Acetaminophen Pharmacokinetics at Delivery.Front Pediatr2021https://conductscience.org/library/papers/34631628PubMed
34616699Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester.Front Pediatr2021https://conductscience.org/library/papers/34616699PubMed
34381745Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology Modeling.Front Pediatr2021https://conductscience.org/library/papers/34381745PubMed
33527213Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir.Clin Pharmacokinet2021https://conductscience.org/library/papers/33527213PubMed
33041711The Revolution in Pediatric Drug Development and Drug Use: Therapeutic Orphans No More.J Pediatr Pharmacol Ther2020https://conductscience.org/library/papers/33041711PubMed
32748112Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery.J Pharmacokinet Pharmacodyn2020https://conductscience.org/library/papers/32748112PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Drugs40

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
AMPRENAVIRCHEMBL116Results1https://conductscience.org/library/drugs/CHEMBL116ChEMBL
ATAZANAVIRCHEMBL1163Results1https://conductscience.org/library/drugs/CHEMBL1163ChEMBL
AMINOSALICYLIC ACIDCHEMBL1169Results1https://conductscience.org/library/drugs/CHEMBL1169ChEMBL
DOLUTEGRAVIRCHEMBL1229211Results1https://conductscience.org/library/drugs/CHEMBL1229211ChEMBL
LINEZOLIDCHEMBL126Results1https://conductscience.org/library/drugs/CHEMBL126ChEMBL
DARUNAVIRCHEMBL1323Results1https://conductscience.org/library/drugs/CHEMBL1323ChEMBL
ABACAVIRCHEMBL1380Results1https://conductscience.org/library/drugs/CHEMBL1380ChEMBL
KANAMYCINCHEMBL1384Results1https://conductscience.org/library/drugs/CHEMBL1384ChEMBL
ETHIONAMIDECHEMBL1441Results1https://conductscience.org/library/drugs/CHEMBL1441ChEMBL
DIDANOSINECHEMBL1460Results1https://conductscience.org/library/drugs/CHEMBL1460ChEMBL
ETONOGESTRELCHEMBL1531Results1https://conductscience.org/library/drugs/CHEMBL1531ChEMBL
EMTRICITABINE, (+/-)-CHEMBL161381Results1https://conductscience.org/library/drugs/CHEMBL161381ChEMBL
FOSAMPRENAVIRCHEMBL1664Results1https://conductscience.org/library/drugs/CHEMBL1664ChEMBL
RILPIVIRINECHEMBL175691Results1https://conductscience.org/library/drugs/CHEMBL175691ChEMBL
AMIKACINCHEMBL177Results1https://conductscience.org/library/drugs/CHEMBL177ChEMBL
COBICISTATCHEMBL2095208Results1https://conductscience.org/library/drugs/CHEMBL2095208ChEMBL
TERIZIDONECHEMBL2107553Results1https://conductscience.org/library/drugs/CHEMBL2107553ChEMBL
DELAMANIDCHEMBL218650Results1https://conductscience.org/library/drugs/CHEMBL218650ChEMBL
CAPREOMYCINCHEMBL2221250Results1https://conductscience.org/library/drugs/CHEMBL2221250ChEMBL
TIPRANAVIRCHEMBL222559Results1https://conductscience.org/library/drugs/CHEMBL222559ChEMBL

See all 40 drugsDownload CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32451908

GET https://conductscience.org/api/papers/v1/32451908/references?page=2